Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Inventor Kerry Combs
Introduction
Kerry Combs is a prominent inventor based in Wallingford, Connecticut, known for her significant contributions to the field of pharmaceutical chemistry. With two patents to her name, she focuses her research on developing compounds that target metabolic disorders, particularly those related to insulin resistance and hyperglycemia.
Latest Patents
Kerry Combs has developed two notable patents that target serious health issues. Her first patent involves "Substituted Carboxylic Acids," which outlines compounds and pharmaceutically acceptable salts that are effective in treating metabolic disorders associated with insulin resistance and hyperglycemia. This invention emphasizes inhibitors of protein tyrosine phosphatase (PTP-1B) that play a crucial role in the treatment of diabetes and other diseases mediated by PTP-1B, including cancer and neurodegenerative disorders.
The second patent, titled "Heterocycle Substituted Carboxylic Acids," shares a similar focus, introducing compounds that also inhibit protein tyrosine phosphatases, specifically PTP-1B. The compounds are useful in formulating pharmaceutical compositions and methods for treating the specified conditions.
Career Highlights
Kerry Combs is affiliated with The Institute for Pharmaceutical Discovery, LLC, where she furthers her innovative research on pharmaceutical development. Through her work, she aims to create effective treatments for serious health conditions, significantly impacting the future of medicine.
Collaborations
During her career, Kerry has collaborated with talented professionals in the field, including her coworkers Michael C Van Zandt and Darren Whitehouse. These collaborations enable her to enhance her research and foster innovation in pharmaceutical discoveries.
Conclusion
Kerry Combs is a distinguished inventor whose work in chemical compounds offers hope for treating metabolic disorders and other serious diseases. Her patents reflect her dedication to advancing medical science and improving patient care, showcasing the importance of innovation in the pharmaceutical industry.